JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

Search

ResMed Inc

Închisă

SectorSănătate

262.42 4.55

Rezumat

Modificarea prețului

24h

Curent

Minim

251.38

Maxim

264.55

Indicatori cheie

By Trading Economics

Venit

-31M

349M

Vânzări

-12M

1.3B

P/E

Medie Sector

26.175

90.422

Randament dividend

0.87

Marjă de profit

26.096

Angajați

10,600

EBITDA

-29M

503M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+18.02% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.87%

2.13%

Următoarele câștiguri

22 apr. 2026

Data viitoare de dividende

19 mar. 2026

Următoarea dată ex-dividende

12 feb. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-539M

37B

Deschiderea anterioară

257.87

Închiderea anterioară

262.42

Sentimentul știrilor

By Acuity

9%

91%

8 / 352 Clasament în Healthcare

ResMed Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 feb. 2026, 23:11 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

3 feb. 2026, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3 feb. 2026, 23:50 UTC

Market Talk

Nikkei May Decline After Hitting All-Time High -- Market Talk

3 feb. 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

3 feb. 2026, 23:41 UTC

Achiziții, Fuziuni, Preluări

KKR Makes AI Play With $10.9B Asia Data-Center Deal

3 feb. 2026, 23:38 UTC

Câștiguri

AMD Sales Climb on Help From Data-Center Business -- Update

3 feb. 2026, 23:29 UTC

Achiziții, Fuziuni, Preluări

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

3 feb. 2026, 23:27 UTC

Achiziții, Fuziuni, Preluări

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

3 feb. 2026, 23:25 UTC

Achiziții, Fuziuni, Preluări

KKR-Consortium Expects Deal to Close by Early 2H of 2026

3 feb. 2026, 23:23 UTC

Achiziții, Fuziuni, Preluări

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

3 feb. 2026, 23:22 UTC

Achiziții, Fuziuni, Preluări

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

3 feb. 2026, 23:19 UTC

Market Talk

Australia Gold Miners Tipped to Rally Higher -- Market Talk

3 feb. 2026, 23:19 UTC

Market Talk

Global Equities Roundup: Market Talk

3 feb. 2026, 22:56 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

3 feb. 2026, 22:40 UTC

Câștiguri

Amdocs Extends Collaboration With T-Mobile

3 feb. 2026, 22:39 UTC

Câștiguri

Amdocs 1Q Adj EPS $1.81

3 feb. 2026, 22:39 UTC

Câștiguri

Amdocs 1Q Rev $1.16B

3 feb. 2026, 22:39 UTC

Câștiguri

Amdocs 1Q EPS $1.45 >

3 feb. 2026, 22:38 UTC

Câștiguri

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

3 feb. 2026, 22:30 UTC

Achiziții, Fuziuni, Preluări

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

3 feb. 2026, 22:22 UTC

Achiziții, Fuziuni, Preluări

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

3 feb. 2026, 22:14 UTC

Câștiguri

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

3 feb. 2026, 22:13 UTC

Câștiguri

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

3 feb. 2026, 22:12 UTC

Câștiguri

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

3 feb. 2026, 22:10 UTC

Câștiguri

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

3 feb. 2026, 22:10 UTC

Câștiguri

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

3 feb. 2026, 22:10 UTC

Market Talk

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

3 feb. 2026, 22:10 UTC

Câștiguri

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

3 feb. 2026, 22:09 UTC

Câștiguri

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

3 feb. 2026, 22:09 UTC

Câștiguri

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Comparație

Modificare preț

ResMed Inc Așteptări

Obiectiv de preț

By TipRanks

18.02% sus

Prognoză pe 12 luni

Medie 300.64 USD  18.02%

Maxim 345 USD

Minim 265 USD

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruResMed Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

13 ratings

8

Cumpărare

5

Păstrare

0

Vânzare

Sentiment

By Acuity

8 / 352 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat